Allscripts Healthcare Solutions (MDRX) swung to a net loss for the quarter ended Mar. 31, 2017. The company has made a net loss of $20 million, or $ 0.11 a share in the quarter, against a net profit of $2 million, or $0.01 a share in the last year period. On the other hand, adjusted net income for the quarter stood at $23.10 million, or $0.13 a share compared with $25 million or $0.13 a share, a year ago. Revenue during the quarter grew 19.65 percent to $413.50 million from $345.60 million in the previous year period. Gross margin for the quarter contracted 74 basis points over the previous year period to 43.22 percent. Total expenses were 97.27 percent of quarterly revenues, up from 96.56 percent for the same period last year. That has resulted in a contraction of 71 basis points in operating margin to 2.73 percent.
Operating income for the quarter was $11.30 million, compared with $11.90 million in the previous year period.
However, the adjusted operating income for the quarter stood at $55.80 million compared to $42.30 million in the prior year period. At the same time, adjusted operating margin improved 125 basis points in the quarter to 13.49 percent from 12.24 percent in the last year period.
"Allscripts begins 2017 on a solid footing," Paul M. Black, chief executive officer of Allscripts, said. "We saw excellent uptake of solutions and services throughout our client base during the first quarter. I am pleased by the continued confidence our clients are placing in us by expanding the breadth of their relationship with the company across clinical, financial and population health offerings. Bookings growth illustrated that our strategy to deliver a complete scope of solutions across the healthcare continuum is paying off, as providers around the world partner with us to lead the change to smarter care. We reiterate the companys financial outlook for non-GAAP revenue, Adjusted EBITDA and non-GAAP earnings per share in 2017."
Allscripts Healthcare Solutions projects adjusted revenue to be in the range of $1,710 million to $1,740 million for financial year 2017.
Operating cash flow remains almost stableAllscripts Healthcare Solutions has generated cash of $75.50 million from operating activities during the quarter, down 0.53 percent or $ 0.40 million, when compared with the last year period. The company has spent $52.50 million cash to meet investing activities during the quarter as against cash outgo of $23.40 million in the last year period.
The company has spent $15.60 million cash to carry out financing activities during the quarter as against cash outgo of $69.80 million in the last year period.
Cash and cash equivalents stood at $104.40 million as on Mar. 31, 2017, up 4.30 percent or $4.30 million from $100.10 million on Mar. 31, 2016.
Working capital remains negative
Working capital of Allscripts Healthcare Solutions was negative $71.20 million on Mar. 31, 2017 compared with negative $3.57 million on Mar. 31, 2016. Current ratio was at 0.90 as on Mar. 31, 2017, down from 0.99 on Mar. 31, 2016.
Days sales outstanding were almost stable at 45 days for the quarter, when compared with the last year period.
At the same time, days payable outstanding went up to 25 days for the quarter from 17 for the same period last year.
Debt increases substantially
Allscripts Healthcare Solutions has witnessed an increase in total debt over the last one year. It stood at $1,328.10 million as on Mar. 31, 2017, up 121.42 percent or $728.28 million from $599.82 million on Mar. 31, 2016. Total debt was 34.96 percent of total assets as on Mar. 31, 2017, compared with 22.86 percent on Mar. 31, 2016. Debt to equity ratio was at 1.12 as on Mar. 31, 2017, up from 0.43 as on Mar. 31, 2016. Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: editor@irisindia.net